| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Mar-07 | | Total Revenue | 191,292 | 179,358 | 189,892 | 278,399 | | Cost of Revenue | 83,611 | 94,939 | 102,688 | 107,506 | | | Gross Profit |
-
|
-
|
-
| 170,893 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 54,128 | 53,827 | 45,338 | 35,013 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 12,366 | 11,124 | 8,855 | 16,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
|
-
|
-
| 119,880 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 41,187 | 19,468 | 33,011 | 119,880 | | Interest Expense | 21,964 | 28,682 | 29,639 | 77,951 | | Income Before Tax | 19,223 | (9,214) | 3,372 | 41,929 | | Income Tax Expense | 7,886 | (3,889) | 2,761 | 13,209 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,337 | (5,325) | 611 | 28,720 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,337 | (5,325) | 611 | 28,720 | | Preferred Stock And Other Adjustments |
-
|
-
| (4,614) | (9,228) | | | Net Income Applicable To Common Shares | $11,337 | ($5,325) | ($4,003) | $19,492 |
|
0.24% Nasdaq 
0.13%
Income Statement
